Cancer BiologybioRxiv
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
A. L. Hong, Y.-Y. Tseng, J. A. Wala…·W. Hahn
This study identifies SMARCB1 loss as critical for RMC survival and shows proteasome inhibition as a potential therapeutic strategy.
DOI 10.7554/elife.44161